↓ Skip to main content

Sodium–Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice

Overview of attention for article published in Frontiers in Pharmacology, October 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sodium–Glucose cotransporter 2 inhibitor empagliflozin decreases ventricular arrhythmia susceptibility by alleviating electrophysiological remodeling post-myocardial-infarction in mice
Published in
Frontiers in Pharmacology, October 2022
DOI 10.3389/fphar.2022.988408
Pubmed ID
Authors

Genlong Xue, Xiaolei Yang, Ge Zhan, Xin Wang, Jinghan Gao, Yong Zhao, Xinying Wang, Jiatian Li, Zhenwei Pan, Yunlong Xia

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 9%
Professor 1 9%
Student > Doctoral Student 1 9%
Lecturer > Senior Lecturer 1 9%
Unknown 7 64%
Readers by discipline Count As %
Medicine and Dentistry 2 18%
Unspecified 1 9%
Unknown 8 73%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2022.
All research outputs
#20,903,227
of 23,530,272 outputs
Outputs from Frontiers in Pharmacology
#10,830
of 17,123 outputs
Outputs of similar age
#352,944
of 441,628 outputs
Outputs of similar age from Frontiers in Pharmacology
#784
of 1,464 outputs
Altmetric has tracked 23,530,272 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,123 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,628 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,464 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.